Dr. Alexis Turgeon, MD
Claim this profileCHU de Québec - Université Laval
Affiliated Hospitals
CHU De Québec - Université Laval
CHU De Québec-Université Laval, Hôpital De Lènfant Jésus
Clinical Trials Alexis Turgeon, MD is currently running
Multiple Treatments
for Pneumonia
REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform trial for community-acquired pneumonia. The purpose of this study is to evaluate the effect of a range of interventions to improve outcome of patients admitted to intensive care with community-acquired pneumonia. In addition, REMAP-CAP provides and adaptive research platform for evaluation of multiple treatment modalities in the event of a respiratory pandemic such as COVID-19. REMAP-COVID is a sub-platform of REMAP-CAP that evaluates treatments specific to COVID-19 in the United States of America.
Recruiting
3 awards
Phase 3
3 criteria
Heparin
for Community-Acquired Pneumonia
This trial is testing if higher doses of heparin, a blood thinner, can help patients hospitalized with pneumonia. These patients often have blood clot complications that worsen their condition. By preventing these clots, heparin might improve their recovery and reduce severe outcomes. Heparin has been shown to reduce the risk of blood clots in various patients, including those hospitalized for medical conditions and surgeries.
Recruiting
2 awards
Phase 3
5 criteria
More about Alexis Turgeon, MD
Clinical Trial Related
5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Alexis Turgeon, MD has experience with
- Interferon Beta-1a
- Heparin
- Ascorbic Acid
- Placebo
- ARBs
- Artesunate
Breakdown of trials Alexis Turgeon, MD has run
Community-acquired Pneumonia
I Am A Healthy Volunteer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alexis Turgeon, MD specialize in?
Alexis Turgeon, MD focuses on Pneumonia and Community-acquired Pneumonia. In particular, much of their work with Pneumonia has involved treating patients, or patients who are undergoing treatment.
Is Alexis Turgeon, MD currently recruiting for clinical trials?
Yes, Alexis Turgeon, MD is currently recruiting for 3 clinical trials in Québec Quebec. If you're interested in participating, you should apply.
Are there any treatments that Alexis Turgeon, MD has studied deeply?
Yes, Alexis Turgeon, MD has studied treatments such as Interferon beta-1a, Heparin, Ascorbic Acid.
What is the best way to schedule an appointment with Alexis Turgeon, MD?
Apply for one of the trials that Alexis Turgeon, MD is conducting.
What is the office address of Alexis Turgeon, MD?
The office of Alexis Turgeon, MD is located at: CHU de Québec - Université Laval, Québec, Quebec G1J 1Z4 Canada. This is the address for their practice at the CHU de Québec - Université Laval.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.